<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IRMD
iRadimed
$
()


  • iRadimed sees Q1 adjusted EPS 33c-35c, consensus 41c

    2/8/2024 - 08:14am
  • iRadimed sees FY24 adjusted EPS $1.52-$1.62, consensus $1.67

    2/8/2024 - 08:14am
  • iRadimed reports Q4 adjusted EPS 39c, consensus 40c

    2/8/2024 - 08:12am
  • iRadimed reports preliminary Q4 revenue $17.5M, consensus $17.13M

    1/9/2024 - 08:32am
  • iRadimed declares special dividend of 48c, initiates quarterly dividend

    12/12/2023 - 10:02am
  • iRadimed management to meet with Lake Street

    11/30/2023 - 04:55am
  • iRadimed management to meet with Lake Street

    11/24/2023 - 10:39am
  • iRadimed sees FY23 adjusted EPS $1.48-$1.51, consensus $1.39

    11/3/2023 - 08:05am
  • iRadimed sees Q4 adjusted EPS 38c-41c, consensus 36c

    11/3/2023 - 08:04am
  • iRadimed reports Q3 adjusted EPS 43c, consensus 36c

    11/3/2023 - 08:04am
  • iRadimed price target raised to $55 from $50 at Roth MKM

    8/8/2023 - 07:53am
  • iRadimed price target raised to $60 from $55 at Lake Street

    8/3/2023 - 14:40pm
  • iRadimed reports Q2 EPS 36c, consensus 31c

    8/3/2023 - 08:06am
  • iRadimed management to meet virtually with Lake Street

    5/17/2023 - 04:55am
  • iRadimed management to meet virtually with Lake Street

    5/9/2023 - 13:04pm
dynamic_feed Breaking News